REC Ltd. announces an acquisition

The RBI’s 15 October 2026 NOC is conditional, not an unconditional merger approval. The exchange disclosure confirms that the NOC is subject to instructions and conditions contained in the RBI communication, but it does not reproduce the specific RBI conditions. The merger also remains subject to shareholder, creditor and other statutory or regulatory approvals. ^[1]

What the applicable RBI framework requires

The RBI’s NBFC voluntary-amalgamation directions establish the relevant stipulations:

• Both NBFCs must obtain the RBI’s NOC before approaching the Tribunal for the merger.
• After amalgamation, the merged NBFC must surrender the Certificate of Registration of the amalgamated entity for cancellation.
• Separate prior RBI approval is required where the transaction involves a change in control, a change of 26% or more in paid-up equity shareholding, or a change in management affecting more than 30% of the directors, excluding independent directors. ^[2]

These are framework-level requirements. The precise additional conditions in REC’s RBI NOC cannot be identified from the exchange announcement because the NOC text itself has not been reproduced.

Alignment with the latest quarterly compliance disclosures

REC’s Q1 FY27 disclosures are broadly consistent with the prudential requirements visible in the record:

The investor presentation further breaks the 23.06% CRAR into Tier I of 21.32% and Tier II of 1.74%. ^[4]

Analytical implication: the latest quarterly disclosures provide evidence that REC was comfortably above the stated capital adequacy threshold and had very low reported Stage-3 assets when the merger process was progressing. That supports alignment with the prudential rationale behind an RBI merger review. However, it does not establish that every condition in the RBI’s NOC has been met, because the individual NOC stipulations—such as any requirements on post-merger capital treatment, asset classification continuity, provisioning, governance, or regulatory reporting—are not set out in the cited public announcement.

The separate debenture-trustee NOCs should not be confused with the RBI NOC: those contain explicit conditions on continuing compliance with existing debenture-trust-deed terms, maintaining security cover and obtaining required creditor approvals. ^[5]

The disclosed material does not support a quantified projection for either the combined CAR or the DISCOM-overlap concentration risk. It establishes the scale of the combination, but not the pro-forma capital, risk-weighted assets, or borrower-level exposure overlap needed to calculate those impacts.

CAR impact

REC’s standalone CRAR was 23.06% as of 30 June 2026, including Tier-I capital of 21.32% and Tier-II capital of 1.74% ^[4]. The merger announcement, however, does not provide PFC’s corresponding CAR, the combined pro-forma risk-weighted assets, regulatory capital adjustments, or the post-merger capital impact of the share issuance. It only reports FY26 net worth of Rs 84,290 Crores for REC standalone and Rs 1,02,532 Crores for PFC standalone ^[6].

Accordingly, the combined CAR cannot be inferred by averaging REC’s and PFC’s standalone ratios. The relevant calculation is:

Combined CAR = eligible regulatory capital after merger / combined risk-weighted assets

The ratio could be lower than REC’s standalone 23.06% if PFC contributes relatively high risk-weighted assets or if merger-related regulatory adjustments reduce eligible capital. Conversely, it could remain strong if the combined capital base grows faster than risk-weighted assets. On the cited disclosures, the direction and magnitude are not determinable.

Concentration risk

The transaction is expected to create a financing entity with an aggregate loan book of over Rs 11 lakh Crores ^[7]. That scale does not, by itself, demonstrate diversification. If REC and PFC have overlapping lending to the same state-owned DISCOMs, consolidation would combine those exposures and could increase:

• single-borrower and group concentration;
• state-government or state-utility concentration;
• correlation to power-sector payment cycles and tariff/regulatory outcomes; and
• dependence on the same government support and receivables-resolution mechanisms.

However, the cited merger disclosure does not provide a DISCOM-wise exposure schedule, common-borrower list, or quantified overlap. Therefore, it is not possible to state whether concentration risk will rise, fall, or remain broadly unchanged after netting duplicate exposures.

Analytical conclusion: the merger creates potential scale and capital-efficiency benefits, but the available pro-forma evidence is insufficient to establish a projected CAR outcome. The key unresolved risk is whether the apparent Rs 11 lakh Crore loan book is genuinely diversified or substantially duplicated across the same state-owned DISCOM counterparties. The decisive disclosures would be combined eligible capital, risk-weighted assets, post-merger CRAR, and exposure overlap by DISCOM, state, and borrower group.

No fixed timeline for NCLT, CCI or other remaining approvals is confirmed in the cited exchange filing. The RBI NOC, received on 15 October 2026, removes one regulatory condition, but the Scheme remains subject to further statutory and regulatory approvals and the required shareholder and creditor consents. ^[8]

What is confirmed

• RBI: NOC received on 15 October 2026, subject to the conditions specified by RBI. ^[8]
• NCLT and CCI: The filing does not provide a dated milestone, statutory deadline, or completion target for these approvals. It refers generally to “such other statutory and regulatory approvals” required for the Scheme to become effective. ^[8]
• Stock-exchange process: The Scheme was to be filed with BSE and NSE to obtain their No-Objection Letter under Regulations 37 and 59A of the SEBI Listing Regulations. ^[6]
• Overall status: The merger remains conditional on all requisite regulatory and governmental approvals, along with shareholder and creditor approvals. ^[7]

Shareholder-voting triggers

The disclosed triggers are:

1. The Scheme must proceed under Sections 230–232 of the Companies Act, 2013, which governs the merger process. ^[6] 2. Approval of the respective shareholders and creditors of REC and PFC must be obtained, wherever required under applicable law and the Scheme. ^[8] 3. The Scheme must satisfy the other conditions for effectiveness, including the required regulatory approvals and the conditions specified in the Scheme itself. ^[8]

The cited filings do not specify the meeting dates, the NCLT order convening the meetings, the voting record date, the requisite voting thresholds, or whether any shareholder class will be dispensed with. Accordingly, RBI clearance should be viewed as a regulatory milestone—not as confirmation that the shareholder-voting timetable has been activated or scheduled.